Cover
Acknowledgements
Foreword
List of Contributors
1 Advances in Integrative Dermatology
1. Introduction
2. Integrative Dermatology: Conventional and Complementary Dermatology
3. Pillars of the Integrative Approach
4. Conclusion
5. References
2 Psycho‐Neuro‐Endocrine‐Immunology: A Psychobiological Concept
1. Bidirectional PNEI Cross‐talk in Dermatology: The Gut–Brain–Skin Axis
2. Alteration of PNEI Homeostasis, Inflammation, and Dermatologic Diseases
3. Low‐Dose Medicine (LDM): Theoretical, Physiological, and Biochemical Bases
4. Low‐Dose Medicine and Skin Diseases: Preclinical Studies
5. Low‐Dose Medicine and Skin Diseases: Clinical Results
6. Conclusion
7. References
3 Psychoneurocutaneous Medicine
1. Introduction
2. Classification of Psychodermatological Diseases
3. Dermatitis Artefacta
4. Delusions of Parasitosis
5. Trichotillomania (Hair‐Pulling Disorder)
6. Obsessive‐Compulsive Disorder
7. Excoriation (Skin‐Picking) Disorder
8. Psychogenic Pruritus
9. Management Guidelines
10. Conclusion
11. References
4 Acne
1. Introduction and Epidemiology
2. Clinical Features and Classification
3. Perspective of Multifactorial Etiopathogenesis and Relevance of an Integrative Approach
4. Psychopathology and Quality of Life Impairment: An Overview
5. Assessment of Patients with Acne
6. Management
7. Conclusion
8. References
5 Rosacea
1. Introduction and Epidemiology
2. Risk Factors and Triggers
3. Quality of Life
4. Associated Diseases
5. Pathogenesis
6. Clinical Variants
7. Imagistic Approach
8. Approach
9. Local Treatment
10. General Treatment
11. Laser Treatment
12. Complementary Medicine
13. Rosacea Management
14. References
6 Seborrheic Dermatitis
1. Introduction and Epidemiology
2. Pathogenesis
3. Psychological Aspects
4. Clinical Presentation
5. Diagnosis
6. Treatment
7. Conclusion
8. References
7 Autoimmune Skin Disorders
1. Introduction
2. Lupus Erythematosus
3. Collagen Vascular Skin Disorders
4. Scleroderma
5. Dermatomyositis
6. Pemphigus Vulgaris
7. Alopecia Areata
8. Other Inflammatory Skin Disorders
9. Focus on Nonconventional Treatments
10. References
8 Vitiligo
1. Introduction
2. Genetics of Vitiligo
3. Epigenetics in Vitiligo – The Importance of Environmental Factors
4. Pathobiology
5. Health‐Related Quality of Life
6. Treatment
7. References
9 The Combined Approach to Atopic Dermatitis
1. Introduction
2. Program for Adults and Older Children
3. Treatment Outcome with Program for Adults and Older Children
4. Program for Younger Children and Their Parents
5. Treatment Outcome with Program for Younger Children and their Parents
6. Delivering the Combined Approach for AD
7. Conclusion
8. References
10 Psoriasis
1. Introduction
2. Genetics of Psoriasis
3. Epigenetics in Psoriasis – The Importance of Environmental Factors
4. Metabolomics and Microbiome
5. Health‐Related Quality of Life
6. Treatment
7. References
11 Urticaria
1. Introduction
2. Etiology and Pathology of Urticaria
3. Major Cells, Mediators, and Immunopathogenesis of Urticaria
4. Role of Autologous Serum Skin Test (ASST)
5. Endothelium and Coagulation System in CSU
6. Role of Angiogenesis in CSU
7. Diagnosis
8. Therapy
9. References
12 Lichen Planus and Lichenoid Disorders
1. Introduction
2. Pathogenesis
3. Clinical Manifestations
4. Emotional and Mental Aspects
5. Diagnosis
6. Treatment
7. Complementary and Alternative Treatments
8. Lichenoid Reactions
9. Oral Lichenoid Contact Reactions
10. Conclusion
11. References
13 Itch: An Integrative Approach
1. Introduction
2. Definition and Classification
3. Epidemiology and Clinical Features
4. Pathogenesis
5. Burden of the Disease
6. Diagnosis
7. Treatment
8. Conclusion
9. References
14 Infections of the Skin
1. Infections of the Skin Caused by Bacteria
2. Infections of the Skin Caused by Viruses
3. Infections of the Skin Caused by Fungi
4. Infections of the Skin Caused by Parasites
5. Infections of the Skin Caused by Mycobacteria
6. Sexually Transmitted Infections
7. References
15 Nonmelanoma Skin Cancer
1. Introduction
2. Etiology
3. Basal Cell Carcinoma (BCC)
4. Squamous Cell Carcinoma (SCC)
5. Management
6. Psychological Aspects of NMSC
7. Conclusion
8. References
16 Melanoma
1. Introduction
2. Epidemiology
3. Clinical Manifestation
4. Fast‐Growing and Slow‐Growing Melanomas
5. Three Roots of Melanoma
6. Anatomical Localization
7. Melanoma in Different Skin Colors
8. Risk Factors
9. Diagnosis
10. Conclusion
11. References
17 The Microbiome in Hair Disorders
1. Introduction
2. Microbiome Research in Dermatology
3. Harnessing the Microbiome
4. References
18 Integrative Treatment for Chronic Wounds
1. Introduction
2. Phases of Acute Wound Healing
3. Categories of Chronic Wounds
4. Psychosocial Impact of Chronic Wounds
5. The Role of Stress in Wound Healing
6. Physical and Environmental Aspects of Chronic Wounds
7. Conventional Treatment of Ulcers
8. Adjuvant Therapies
9. Specific Disease Treatment
10. Complementary and Alternative Treatments of Chronic Wounds
11. Future Directions and Conclusion
12. References
19 Diet and Skin
1. Introduction
2. Diet and Specific Diseases
3. Nutrition and Oxidative Stress
4. Brain–Gut–Skin Axis
5. Microbiota
6. Leaky Gut
7. Conclusion
8. References
20 Supplements and Skin
1. Introduction
2. Healthy Diet
3. Nutraceuticals and Supplementation
4. Nutritional Support for Wound Healing and Skin Ulcers (Regenerative Medicine Treatment)
5. References
21 Water and Dermatology
1. Introduction
2. Dry Skin and Other Disorders
3. Transepidermal Water Loss (TEWL)
4. Maintaining Skin Integrity in the Aged
5. Preventing and Treating Dry Skin
6. Aquagenic Skin Diseases
7. How Irritating Is Water?
8. Water in Dermatological Treatment
9. Conclusion
10. References
22 Sleep and Skin
1. Introduction
2. Sleep
3. Sleep and Skin
4. Skin Diseases and Sleep Problems
5. Diagnosis and Treatment
6. Conclusion
7. References
23 Exercise and Skin
1. Introduction
2. Exercise and Acne
3. Exercise and Cellulite
4. Exercise and Dermatitis
5. Exercise and Eczema
6. Exercise and Folliculitis
7. Exercise and Psoriasis
8. Exercise and Urticaria
9. Exercise and Vasculitis
10. Exercise and Vitiligo
11. Conclusion
12. References
24 Skin and Pollution
1. Environmental Pollution and Its Effects on the Skin
2. Air Pollution
3. Water and Food Pollution
4. Mechanism of Skin Damage
5. Air Pollution and Skin Disease
6. Antipollution Skin Care
7. Conclusion
8. References
25 Cosmeceuticals
1. Introduction
2. Antiaging Cosmeceuticals
3. Skin‐Lightening Cosmeceuticals
4. Botanicals
5. Conclusion
6. References
26 Botulinum Toxin
1. Introduction
2. Physiology
3. Patient Assessment and Selection
4. The Procedure
5. Noncosmetic Dermatological Uses
6. Conclusion
7. References
27 Ayurvedic Dermatology
1. Introduction
2. Ayurveda and the Skin
3. Etiology
4. Diagnosis and Management
5. Classical Treatment of Specific Conditions
6. An Overview of Ayurvedic Medicinal Preparations
7. Evidence‐Based Research
8. References
28 Acupuncture
1. Introduction
2. Pathogenic Factors
3. Meridians and Acupuncture Points
4. Differentiation of Syndromes
5. General Principles of Treatment
6. Conclusion
7. References
29 Moxibustion in Dermatology
1. Introduction
2. Types of Treatment
3. Mechanism of Action
4. Side Effects
5. Conclusion
6. References
30 Cupping Treatment in Dermatology
1. Introduction
2. Method of Treatment
3. Adverse Effects
4. Conclusion
5. References
31 Biofeedback
1. Introduction
2. Epigenetics and Psycho‐Neuro‐Endocrino‐Immunology
3. Brain‐Skin Connection
4. Biofeedback for Skin Disorders
5. Definition
6. Approaches and Disciplines Behind Biofeedback
7. Instrument and Mechanism of Action
8. Efficacy
9. Conclusion
10. References
32 Meditation, Hypnosis, and Psychotherapy for Skin Disorders
1. Introduction
2. Meditation
3. Hypnosis
4. Psychotherapy
5. Cognitive Hypnotherapy
6. Mindfulness‐Based Cognitive Hypnotherapy
7. References
33 Dermatoethics and Dermatobioethics in Integrative Dermatology
1. Introduction
2. Ethics and Bioethics
3. Principles of Bioethics
4. Dermatoethics and Dermatobioethics
5. Conclusion
6. References
Index
End User License Agreement

List of Tables

Chapter 1
1. Table 1.1 Integrative dermatology healthcare model: key questions‐ by França ...
Chapter 2
1. Table 2.1 List of the major published works in the field of Low‐Dose Medicine...
Chapter 4
1. Table 4.1 Acne: spectrum of cutaneous lesions and classification.
2. Table 4.2 Acne assessment: an integrative approach.
3. Table 4.3 Acne: conventional treatment.
Chapter 6
1. Table 6.1 Pathogenic factors of seborrheic dermatitis.
2. Table 6.2 Differential diagnosis of seborrheic dermatitis.
3. Table 6.3 Treatment of scalp seborrheic dermatitis.
4. Table 6.4 Treatment of non‐scalp seborrheic dermatitis.
Chapter 8
1. Table 8.1 Subtypes of vitiligo.
2. Table 8.2 Classification of vitiligo based on the clinical features and natur...
3. Table 8.3 Common autoimmune diseases associated with vitiligo.
4. Table 8.4 Genetic alterations which may be detected in vitiligo patients.
5. Table 8.5 Trigger factors that may be involved in vitiligo onset.
6. Table 8.6 Natural antioxidants which may be introduced with diet.
7. Table 8.7 Common topical drugs most commonly used in vitiligo treatment.
8. Table 8.8 Traditional phototherapies.
9. Table 8.9 Herbal natural compounds useful for vitiligo treatments.
10. Table 8.10 Most Common surgical procedures for vitiligo treatment.
Chapter 10
1. Table 10.1 Incidence rates for psoriasis.
2. Table 10.2 Psoriasis – medical treatments.
Chapter 12
1. Table 12.1 Conventional and emerging therapies for treatment of CLP and OLP. ...
2. Table 12.2 Causative agents of oral lichenoid contact reactions.
Chapter 13
1. Table 13.1 Examples of conditions associated with CI.
2. Table 13.2 Dermatoses associated with CI.
3. Table 13.3 Cortical regions and their associated functions in relation to itc...
4. Table 13.4 Mediators of itch listed alphabetically.
5. Table 13.5 Clinical data and possible underlying causes of itch.
6. Table 13.6 First‐step lab screening for possible causes of CI.
7. Table 13.7 Treatment modalities for itch.
8. Table 13.8 Miscellaneous cutaneous and systemic disorders presenting with itc...
9. Table 13.9 Biologic drugs that exert proven effect on itch in underlying derm...
Chapter 14
1. Table 14.1 Conventional therapy in viral infections of the skin.
Chapter 16
1. Table 16.1 Melanoma clinical subtypes.
2. Table 16.2 Risk factors for melanoma (summary).
Chapter 18
1. Table 18.1 Types of dressings.
2. Table 18.2 Specific wound therapy in addition to local wound care [17].
3. Table 18.3 Summary of complementary and alternative treatments of chronic wou...
Chapter 19
1. Table 19.1 Summary of dietary interventions cited above for skin disease.
2. Table 19.2 Anti‐inflammatory dietary parameters.
3. Table 19.3 Functional foods used in skin disease studies.
4. Table 19.4 Effects of Prebiotics and Probiotics on the modulation of gastroin...
5. Table 19.5 Connection between gastrointestinal disorders and dermatological d...
6. Table 19.6 Dietetic composition recommendations.
7. Table 19.7 Influence of supplements on intestinal permeability.
8. Table 19.8 Probiotic effects on gut barrier function.
Chapter 20
1. Table 20.1 Supplement dosage as reported in the primary literature.
Chapter 21
1. Table 21.1 Water‐related dermatoses [15–17].
Chapter 24
1. Table 24.1 Common causative agents of occupational contact dermatitis.
Chapter 25
1. Table 25.1 Skin‐lightening cosmeceuticals.
2. Table 25.2 Commonly used botanical skin‐lightening agents [74].
Chapter 26
1. Table 26.1 Muscle anatomy.
2. Table 26.2 BoNT doses in males and females.
Chapter 29
1. Table 29.1 Moxibustion indications in dermatology [22].
2. Table 29.2 Adverse effects of moxibustion [6].
Chapter 30
1. Table 30.1 Types of cups and their origin [2].
2. Table 30.2 Indications of cupping treatment [5].
3. Table 30.3 Indications of cupping treatment in dermatology [15].
Chapter 31
1. Table 31.1 Major stress mediators in the skin and cutaneous appendages.
2. Table 31.2 Cutaneous affections reported to have high incidence of psychoemot...
3. Table 31.3 Efficacy ratings for biofeedback training on different medical con...

List of Illustrations

Chapter 1
1. Figure 1.1 Integrative dermatology: combination of conventional dermatology a...
2. Figure 1.2 Pillars and principles of integrative dermatology by França and Lo...
Chapter 2
1. Figure 2.1 Schematic representation of homeostatic control systems within the...
2. Figure 2.2 Schematic representation of the action of proinflammatory triggers...
3. Figure 2.3 Schematic representation of the keratinocytes‐melanocytes cross‐ta...
4. Figure 2.4 Biological concentration‐dependent effects of signaling molecules....
Chapter 4
1. Figure 4.1 Moderate acne, with comedonal and papulopustular lesions.
2. Figure 4.2 Nodulocystic acne.
3. Figure 4.3 Acne excoriée.
Chapter 5
1. Figure 5.1 Clinical Aspect of Rosacea.
2. Figure 5.2 Noninvasive evaluation.
3. Figure 5.3 Correlation clinical lesions with vascular modifications.
4. Figure 5.4 Before and after – azythromicin and azelaic acid treatment.
5. Figure 5.5 Clinical lesions before and after NdYAG laser.
6. Figure 5.6 Laser Nd‐YAG effects on vascular lesion.
Chapter 7
1. Figure 7.1 Multiple factors involved in the autoimmune skin diseases' pathoge...
2. Figure 7.2 Pemphigus is an autoimmune disease where many other factors influe...
3. Figure 7.3 Autoimmune pathway triggered by stress in alopecia areata.
Chapter 9
1. Figure 9.1 Synonymous terms.
2. Figure 9.2 The atopic triad.
3. Figure 9.3 Conventional stepped treatment for AD.
4. Figure 9.4 Conventional ancillary AD treatment.
5. Figure 9.5 Complementary and Alternative Treatment for AD.
6. Figure 9.6 Treatment stages – adults and older children.
7. Figure 9.7 Three levels of treatment.
8. Figure 9.8 Habit reversal for chronic AD.
9. Figure 9.9 Treatment stages – younger children.
Chapter 12
1. Figure 12.1 Classical erythematous to violaceous, flat‐topped, polygonal papu...
2. Figure 12.2 Alternative/complementary treatment modalities used in the integr...
3. Figure 12.3 Severe plaque‐like OLDR with dysphagia in a patient receiving ima...
Chapter 15
1. Figure 15.1 Basal cell carcinoma on the scalp before Mohs Micrographic Surger...
2. Figure 15.2 After Mohs Micrographic Surgery – lesion removed.
Chapter 16
1. Figure 16.1 Superficial spreading melanoma with nodular part. History of the ...
2. Figure 16.2 Nodular amelanotic melanoma, fast‐growing type. History of the le...
3. Figure 16.3 Lentigo maligna. Slow‐growing melanoma on sun‐exposed area. Histo...
4. Figure 16.4 Nodular amelanotic melanoma with lack of positive ABCD criteria, ...
Chapter 18
1. Figure 18.1 Venous leg ulcer.
Chapter 19
1. Figure 19.1 The link between gastrointestinal disorders, microbiota imbalance...
Chapter 24
1. Figure 24.1 Fiberglass dermatitis and nail dystrophy in a fiberglass worker. ...
2. Figure 24.2 Recurrent airborne allergic contact dermatitis caused by nonoccup...
3. Figure 24.3 The positive patch test reaction to colophony (rosin) and nickel ...
Chapter 25
1. Figure 25.1 The structure of retinoids.
Chapter 26
1. Figure 26.1 Reconstitution of BoNT. [11]
2. Figure 26.2 Anatomy of Corrugator supercilii and procerus muscle.
3. Figure 26.3 Injection points for glabellar frown lines.
4. Figure 26.4 (a) Glabellar lines, U pattern. (b) Injection points for U patter...
5. Figure 26.5 (a) Glabellar lines, V pattern. (b) Injection points for V patter...
6. Figure 26.6 (a) Glabellar lines, omega pattern. (b) Injection points for omeg...
7. Figure 26.7 (a) Inverted omega pattern. (b) Injection points for inverted ome...
8. Figure 26.8 (a) Converging points pattern. (b) Injection points for convergin...
9. Figure 26.9 (a) Glabellar frown lines before injection. (b) Glabellar frown l...
10. Figure 26.10 Frontalis muscle anatomy.
11. Figure 26.11 Injection points for forehead lines.
12. Figure 26.12 Two bellies of frontalis.
13. Figure 26.13 Single belly of frontalis.
14. Figure 26.14 (a) Forehead lines before injection. (b) Forehead lines after in...
15. Figure 26.15 Spock's brow.
16. Figure 26.16 Anatomy of orbicularis oculi muscle.
17. Figure 26.17 Injection points for crow's feet.
18. Figure 26.18 Full fan pattern.
19. Figure 26.19 Central fan pattern.
20. Figure 26.20 Lower fan pattern.
21. Figure 26.21 Upper fan pattern.
22. Figure 26.22 (a) Crow's feet before BoNT injection. (b) Crow's feet after BoN...
23. Figure 26.23 Arched brow injection point.
24. Figure 26.24 Male brow Horizontal.
25. Figure 26.25 Lax skin in a mature female, snap test positive.
26. Figure 26.26 Injection point for infraorbital wrinkles.
27. Figure 26.27 Anatomy of nasalis and LLSAN muscle.
28. Figure 26.28 Bunny's lines injection points.
29. Figure 26.29 (a) Bunny's lines before BoNT injection. (b) Bunny's lines after...
30. Figure 26.30 Gummy smile injection points.
31. Figure 26.31 (a) Gummy smile before BoNT injection. (b) Gummy smile after BoN...
32. Figure 26.32 Injection points for perioral rhytids.
33. Figure 26.33 DAO muscle anatomy.
34. Figure 26.34 DAO injection points.
35. Figure 26.35 (a) DAO before BoNT injection. (b) DAO after BoNT injection.
36. Figure 26.36 Mentalis muscle anatomy.
37. Figure 26.37 Injection points for popply chin.
38. Figure 26.38 (a) Mentalis muscle before BoNT injection. (b) Mentalis muscle a...
39. Figure 26.39 Platysma anatomy.
40. Figure 26.40 Platysmal bands injection points.
41. Figure 26.41 (a) Platysmal bands before BoNT injection. (b) Platysmal bands a...
42. Figure 26.42 (a) Nefertiti lift injection points. (b) Nefertiti lift after in...
43. Figure 26.43 Masseter muscle anatomy.
44. Figure 26.44 Masster injection points.
45. Figure 26.45 (a) Masseter hypertrophy before BoNT injection. (b) Masseter hyp...

Pages

iii
iv
ix
xi
xiii
xiv
xv
xvi
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
25
26
27
28
29
30
31
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
119
120
121
122
123
124
125
126
127
128
129
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
351
352
353
354
355
356
357
358
359
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
503
504
505
506
507
508
509
510
511
513
514
515
516
517
518
519
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535

This edition first published 2019
© 2019 John Wiley & Sons Ltd

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.

The right of Katlein França and Torello Lotti to be identified as the author(s) of the editorial material in this work has been asserted in accordance with law.

Registered Office(s)
John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA
John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK

Editorial Office
9600 Garsington Road, Oxford, OX4 2DQ, UK

For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.

Wiley also publishes its books in a variety of electronic formats and by print‐on‐demand. Some content that appears in standard print versions of this book may not be available in other formats.

Limit of Liability/Disclaimer of Warranty
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting scientific method, diagnosis, or treatment by physicians for any particular patient. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.

Library of Congress Cataloging‐in‐Publication Data

Names: França, Katlein, editor. | Lotti, T. M. (Torello M.), 1953– editor.
Title: Advances in integrative dermatology / edited by Katlein França, Torello Lotti.
Description: Hoboken, NJ : Wiley‐Blackwell, 2019. | Includes bibliographical references. |
Identifiers: LCCN 2018044907 (print) | LCCN 2018045692 (ebook) | ISBN 9781119476092 (Adobe PDF) | ISBN 9781119475880 (ePub) | ISBN 9781119476047 (hardcover)
Subjects: | MESH: Skin Diseases–therapy | Skin Diseases–complications |Complementary Therapies–methods
Classification: LCC RL74 (ebook) | LCC RL74 (print) | NLM WR 650 | DDC 616.5–dc23
LC record available at https://lccn.loc.gov/2018044907

Cover Design: Wiley
Cover Images: © subodhsathe/iStock.com,© kapulya/iStock.com, © CasarsaGuru/Getty Images, © Dawid Garwol/EyeEm/Getty Images

List of Contributors

Yasser Al‐Qubaisy, MD
Department of Dermatology and Dermatological Surgery, Prince Sultan Military Medical City, Riyadh, KSA

Liguori Aldo, MD
Department of Anatomic, Histologic, Forensic Medicine and Locomotor System Sciences, Faculty of Pharmacy and Medicine, Paracelso Institute, Sapienza University, Rome, Italy

Catherine E. Amey, BS
Azienda Ospedaliera San Giovanni di Dio e Ruggi D’Aragona
Salerno, Italy

Paolo Amori, MD
Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Università degli Studi Guglielmo Marconi, Rome, Italy

Victoria Barygina, PhD
Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy

Georgeta Bocheva, MD, PhD
Department of Pharmacology and Toxicology, Medical University, Sofia, Bulgaria

Zeljana Bolanca, MD
Department of Dermatology and Venereology, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Christopher Bridgett, MD
Imperial College, Chelsea & Westminster Hospital, London, UK

José C. Cardoso, MD
Department of Dermatology, Coimbra Hospital and University Centre Coimbra, Portugal

David E. Castillo, MD
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

Jill Chitalia, MD
Department of Dermatology, LTM Medical College and Hospital Sion, Mumbai, India

Victor Gabriel Clatici, MD
DermaLife – Medlife Group, Bucharest, Romania

Aurelio Conte, BS
Azienda Ospedaliera San Giuseppe Moscati
Avellino, Italy

Stefana Cretu, MD
2nd Clinic of Dermatology, Colentina Clinical Hospital, Bucharest, Romania

Farah Daaboul, PhD
Institute of Dermatological and Regenerative Sciences, Florence, Italy

Katerina Damevska, MD, PhD
University Clinic of Dermatology, Ss Cyril and Methodius University, Skopje, Republic of Macedonia

Evan Darwin, BA
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

Reginaldo de França, Msc, PhDc
Universidad del Museo Social Argentino, Buenos Aires, Argentina

Rachita Dhurat, MD
Department of Dermatology, LTM Medical College and Hospital Sion, Mumbai, India

Veronica Di Nardo, PhD
Centro Studi per la Ricerca Multidisciplinare e Rigenerativa Università degli Studi Guglielmo Marconi Rome, Italy

Claudio Feliciani, MD
Dermatology Unit, Deparment of Medicine and Surgery, University of Parma Parma, Italy

Bárbara R. Ferreira, MD
Department of Dermatology, Coimbra Hospital and University Centre Coimbra, Portugal

Américo Figueiredo, MD, PhD
Department of Dermatology, Coimbra Hospital and University Centre Coimbra, Portugal

Francesca Finelli, BS
Azienda Ospedaliera San Giuseppe Moscati Avellino, Italy

Aparecida Porto França, Msc, PhD, PostDoc
Instituto Universitário Italiano de Rosario Rosario, Argentina

Katlein França, MD, PhD
Department of Dermatology & Cutaneous Surgery
Department of Psychiatry & Behavioral Sciences
Institute for Bioethics & Health Policy
Miami, FL, USA
Centro Studi per la Ricerca
Multidisciplinare e Rigenerativa
Univeristà degli Studi Guglielmo
Marconi, Rome, Italy

Serena Gianfaldoni, MD
Department of Dermatology, Università degli Studi Guglielmo Marconi Rome, Italy

Andy Goren, MD
Department of Dermatology and Venereology, Università degli Studi Guglielmo Marconi, Rome, Italy

Ilana Gunczler, MD
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

Xing‐Hua Gao, MD
Department of Dermatology, The First Hospital of China Medical University Shenyang, China

Mohammad Jafferany, MD
Department of Psychiatry, Central Michigan University, Mount Pleasant, MI, USA

Jana Kazandjieva, MD, PhD
Department of Dermatology, Medical University, Sofia, Bulgaria

Jonette Keri, MD, PhD
Dermatology Service, Miami VA Hospital
and
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

Bisera Kotevska Trifunova, MD
Department of Dermatology, Tokuda Hospital, Sofia, Bulgaria

Maja Kovacevic, MD
Department of Dermatology and Venereology, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Anagha Bangalore Kumar, M.B.B.S
Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA

Hadar Lev‐Tov, MD
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

Jacopo Lotti, PhD
Department of Nuclear, Sub‐nuclear and Radiation Physics, Università degli Studi Guglielmo Marconi, Rome, Italy

Torello Lotti, MD
Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Università degli Studi Guglielmo Marconi, Rome, Italy

Valeria Mateeva, MD
Department of Dermatology and Venereology, Military Medical Academy, Sofia, Bulgaria

John McCoy, PhD
Applied Biology, Inc., Irvine, CA, USA

Ladan Mostaghimi, MD
Wisconsin Psychocutaneous Clinic, Middleton, WI, USA

Suzana Nikolovska, MD, PhD
University Clinic of Dermatology, Ss Cyril and Methodius University, Skopje, Republic of Macedonia

Peter Norén, MD
Laserkliniken in Uppsala, Department of Medical Sciences, Uppsala University Uppsala, Sweden

Paul Pastolero, MD
Department of Psychiatry, Central Michigan University, Mount Pleasant, MI, USA

Karls Raimonds, MD
Department of Infectology and Dermatology Derma Clinic Riga, Dr. R.Karla klīnika Riga Stradins University, Riga, Latvia

Raghavendra Rao, PhD
Health Care Global, Bangalore, India

José P. Reis, MD
Department of Dermatology Coimbra Hospital and University Centre Coimbra, Portugal

Radomir Reszke, MD
Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland

Miriam Rovesti, MD
Dermatology Unit, Deparment of Medicine and Surgery, University of Parma, Parma, Italy

Carmen Maria Salavastru, MD, PhD
Pediatric Dermatology Unit, Carol Davila University of Medicine and Pharmacy Bucharest, Romania

Francesca Satolli, MD
Dermatology Unit, Deparment of Medicine and Surgery, University of Parma Parma, Italy

Adelina Maria Sendrea, MD
2nd Clinic of Dermatology, Colentina Clinical Hospital Developmental and Research Unit, Bucharest, Romania

Jaishree Sharad, MD
Skinfiniti Aesthetic Skin and Laser Clinic Mumbai, India

Aseem Sharma, MD
Department of Dermatology, LTM Medical College and Hospital Sion Mumbai, India

Philip D. Shenefelt, MD
Department of Dermatology and Cutaneous Surgery, College of Medicine, University of South Florida, Tampa, FL, USA

Mirna Situm, MD , PhD
Department of Dermatology and Venereology, University Hospital Center Sestre Milosrdnice Zagreb, Croatia

Sushmitha Grama Srinivasan, M.B.B.S
Department of Radiology, Kempegowda Institute of Medical Sciences Bangalore, India

Andrija Stanimirovic, MD
Department of Clinical Medicine, University of Applied Health Sciences, Zagreb, Croatia

Richard Staughton, MD
Imperial College, Chelsea & Westminster Hospital, London, UK

Jacek C. Szepietowski, MD, PhD
Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland

George Sorin Tiplica, MD, PhD
2nd Clinic of Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Belma Türsen, MD
Tursen Dermatology Clinic, Mersin, Turkey

Ümit Türsen, MD
Department of Dermatology, Mersin University, Mersin, Turkey

Begüm Ünlü, MD
Department of Dermatology, Mersin University, Mersin, Turkey

Snejina Vassileva, MD, PhD
Department of Dermatology and Venereology, Medical University Sofia, Bulgaria

Alexandra R. Vaughn, MD
Department of Dermatology, University of California – Davis, Sacramento, CA, USA

Cristiana Voicu, MD
DermaLife – Medlife Group Bucharest, Romania

Uwe Wollina, MD
Department of Dermatology and Allergology, Academic Teaching Hospital Dresden, Dresden, Germany

Li‐Ping Zhao, MD
Department of Dermatology, General Hospital, Shenyang, China